GNRH1 and breast cancer: The American Society for Reproductive Medicine’s committee opinion clearly states: “GnRH agonists may be offered to breast cancer patients to reduce the risk of premature ovarian insufficiency but should not be used in place of other fertility preservation alternatives” [14].